Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Change in Accured Expenses (2020 - 2024)

RAPT Therapeutics' Change in Accured Expenses history spans 5 years, with the latest figure at $3.1 million for Q4 2024.

  • For Q4 2024, Change in Accured Expenses rose 4452.11% year-over-year to $3.1 million; the TTM value through Dec 2024 reached -$8.5 million, down 215.32%, while the annual FY2024 figure was -$8.5 million, 215.32% down from the prior year.
  • Change in Accured Expenses for Q4 2024 was $3.1 million at RAPT Therapeutics, up from -$4.4 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $7.3 million in Q1 2023 and bottomed at -$6.4 million in Q2 2024.
  • The 5-year median for Change in Accured Expenses is $235500.0 (2021), against an average of $295450.0.
  • The largest annual shift saw Change in Accured Expenses plummeted 543.51% in 2023 before it skyrocketed 4452.11% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at -$2.8 million in 2020, then rose by 7.06% to -$2.6 million in 2021, then surged by 89.95% to -$263000.0 in 2022, then surged by 73.0% to -$71000.0 in 2023, then surged by 4452.11% to $3.1 million in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Change in Accured Expenses are $3.1 million (Q4 2024), -$4.4 million (Q3 2024), and -$6.4 million (Q2 2024).